David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

Episode 4 September 16, 2021 00:39:13
David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies
Product Success Podcast: Quality and Medical Devices
David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

Sep 16 2021 | 00:39:13

/

Show Notes

Leading Patent Attorney David Dykeman discusses how medtech funding is at an all-time high, so optimizing your company’s patent portfolio is paramount.  Patents are the new currency!  In addition, intellectual property (IP) are the keys to the castle and must secure and control it across global partnerships, collaboration and change. 

Other Episodes

Episode 8

October 14, 2021 00:44:05
Episode Cover

Valor Compounding is using QMS to make the patients and prescribers lives easier when ordering prescriptions from a compounding pharmacy

Valor's compound pharmacy business is expanding rapidly and demanded an eQMS system that could support tremendous growth and their unique business processes.  Listen to...

Listen

Episode 3

September 09, 2021 00:46:26
Episode Cover

Carlo Stimamiglio from Alira Health Speaks to Explosive Growth in M&A, Valuations & Trends across MedTech and their CDMOs

ODCM market is growing double-digits along with acquisitions. Fueling these trends is specialization and the increasing value and partnership that OEMs are forging with...

Listen

Episode 7

October 07, 2021 00:41:27
Episode Cover

MSA is realizing “jaw-dropping” benefits across the entire value-chain & enterprise systems

Michael Farr, VP of Operations joins us from MSA, a Safety Company. MSA gains value from the initial customer needs and sales account in...

Listen